Coming soon: treatments for ”winter blues”

Washington, April 30 (ANI): Researchers at the Universities of Edinburgh and Manchester are hopeful they have made a key step towards creating new treatments for Seasonal Affective Disorder (SAD), also known as winter depression or winter blues.

The researchers have discovered two ”body clock” genes that reveal how seasonal changes in hormones are controlled. Eventually, it is hoped that the findings could help lead to new ways to tackle SAD – a form of depression suffered during the winter months.

The researchers have been investigating how genes affect changes in the body caused by the seasons. They found that one of these genes (EYA3) has a similar role in both birds and mammals, showing a common link that has been conserved for more than 300 million years.

Scientists studied thousands of genes in Soay sheep. This breed, which dates back to the Bronze Age, is considered to be one of the most primitive with seasonal body clocks unaffected by cross breeding throughout the centuries.

For a long time, scientists had speculated that a key molecule – termed tuberalin – was produced in the pituitary gland at the base of the brain and sent signals to release hormones involved in driving seasonal changes.

However, until now scientists have had no idea about the nature of this molecule, how it works or how it is controlled.

The team focussed on a part of the brain that responds to melatonin – a hormone known to be involved in seasonal timing in mammals.

The study revealed a candidate molecule for the elusive tuberalin, which communicates within the pituitary gland to signal the release of another hormone – prolactin – when days start getting longer. This helps animals adapt to seasonal changes in the environment.

The researchers subsequently identified two genes – TAC1 and EYA3 – that were both activated early when natural hormone levels rise due to longer days.

Professor Dave Burt, of The Roslin Institute at the University of Edinburgh, said: “For more than a decade scientists have known about the presence of this mysterious molecule tuberalin, but until now nobody has known quite how it worked. Identifying these genes not only sheds light on how our internal annual body clocks function but also shows a key link between birds and mammals that has been conserved over 300 million years.”

The study suggests that the first gene TAC1 could only work when the second gene EYA3 – which is also found in birds – was present. The second gene may act to regulate TAC 1 so that it could be switched on in response to increasing day length.

Professor Andrew Loudon, of the University of Manchester”s Faculty of Life Sciences, said: “A lot of our behaviour is controlled by seasons. This research sheds new light on how animals adapt to seasonal change, which impacts on factors including hibernation, fat deposition and reproduction as well as the ability to fight off diseases.”

The findings have been published in the journal Current Biology. (ANI)

Exercise ‘forestalls osteoporosis’

Washington, Apr 27 (ANI): Physical activity can help forestall osteoporosis, according to Medical College of Georgia researchers.

Declining estrogen levels have long been linked to osteoporosis, but bone density starts to decline years before these levels drop, according to Dr. Joseph Cannon, Kellet Chair in Allied Health Sciences and principal investigator of the National Institute of Aging-funded study. It”s during that time that levels of follicle-stimulating hormone, released by the pituitary gland to help regulate ovarian function, actually increase.

Cannon theorizes that higher levels of FSH decrease bone mineral density by increasing cytokines, regulatory proteins produced by white blood cells. One cytokine in particular, interleukin-1, signals certain cells to transform into osteoclasts, which break down and resorb bone.

“We hypothesize that the higher levels of FSH decrease bone mineral density by influencing the production of cytokines,” said Cannon, who presents his team”s research at the American Physiological Society”s Experimental Biology 2010 conference in Anaheim, Calif. April 24-28.

After measuring FSH and bone mineral density in 36 women between the ages of 20 to 50, the researchers correlated higher FSH levels with lower bone mineral density.

When they incubated FSH with white blood cells isolated from the women, it stimulated production of interleukin-1. Moreover, higher circulating levels of IL-1 correlated with lower bone mineral density, if the levels of interleukin-1 inhibitory factors were taken into account.

Additionally, they found that study participants who exercised more than 180 minutes a week retained greater bone density.

“Our work provides more evidence that physical activity is important for maintaining bone density. It”s a case of ’use it or lose it,”” Cannon said, citing his team’s findings that exercise seemed to promote inhibitory factors that help keep interleukin-1 and bone breakdown under control. (ANI)

Pituitary tumour caused world’s tallest man’s gigantism

Washington, Sept 18 (ANI): The Turkish man crowned as the world’s tallest man suffers from a pituitary tumour which has resulted in his gigantic height.

Sultan Kosen stands eight-foot-one-inch tall and was unveiled as the tallest man in the world by the Guinness World Records.osen’s height is a result of a tumour in his pituitary gland, which has led to an over production of growth hormones, reports the National Geographic News.

The condition called pituitary gigantism has also led his feet to grow to almost 15 inches, while his hands are larger than 10 inches.t was only after the tumour was removed last year, that Kosen stopped growing.

The 27-year old is forced to use crutches as his height has weakened his knee joints.

The now-famous Kosen wants to travel around the world and meet a woman who would like to marry him. (ANI)

World’s tallest man looking for love

London, Sept 17 (ANI): A Turkish man has been officially named as the tallest man in the world, but he says his height often makes him unattractive to girls.

The 27-year-old Sultan Kosen is 8ft 1in tall and has 11in-wide hands and 15in-wide feet.

He was crowned the world’s tallest man at the London launch of the 2010 edition of Guinness World Records.

Sultan says he grew abnormally because of a pituitary gland disorder, which has also forced him to use crutches to walk.

Sultan has been longing for a ladylove and has brighter hopes now that he is famous.

The Daily Express quoted him as saying: “The first thing I want to do is have a car that I can fit in but more than that I want to get married,” he said. “I’ve never had a girlfriend. They were usually scared of me. I’m hoping now that I am famous I will be able to meet lots of girls.”

However, being tall can certainly help.

“I can change light bulbs and hang curtains without needing a ladder,” he added. (ANI)

Fireflies, jellyfish genes shedding light on causes of infertility, autoimmune diseases

Washington, March 28 (ANI): Studies on fireflies and jellyfish’s genes are providing significant insights into the possible causes of infertility and autoimmune diseases in humans, says a report.

The article states that with the aid of the luminescent and florescent genes, scientists illuminate cells that produce a hormone linked to conditions, which include rheumatoid arthritis and lupus.

It further says that the technique may be prove useful for tracking the production of the hormone prolactin, which is crucial in ensuring supplies of breast milk in nursing mothers, but can be overproduced by some pituitary tumours, causing infertility.

Prolactin has been linked to more than 300 biological functions, and is believed to play a role in autoimmune diseases like lupus and rheumatoid arthritis, besides the inflammation of cells and tissues.

According to the write-up, scientists from the Universities of Edinburgh, Manchester and Liverpool have been successful in using genes from fireflies and jellyfish to create a chemical reaction to light up cells expressing prolactin in rats.

The technique means that scientists can identify when and where prolactin is expressed to look at how the hormone works in real time.

Sabrina Semprini, whose study is published in the journal Molecular Endocrinology, said: “The lighting up of cells expressing this hormone will help us to understand its role within the body and could help research looking for treatments for conditions in which prolactin is involved.”

The research, funded by the Wellcome Trust, identified cells producing prolactin throughout the body, which included the pituitary gland, the thymus – an organ in the chest which helps protect against autoimmunity – the spleen and inflammatory cells in the abdominal cavity. (ANI)